Inovio Pharmaceuticals
INO
#9619
Rank
NZ$0.17 B
Marketcap
NZ$2.14
Share price
2.52%
Change (1 day)
-2.60%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): NZ-$4.80

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$5.04. In 2024 the company made an earnings per share (EPS) of NZ-$6.92 an increase over its 2023 EPS that were of NZ-$10.66.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.80-30.53%
2024NZ-$6.92-35.14%
2023NZ-$10.66-56.62%
2022NZ-$24.58-19.54%
2021NZ-$30.5535.9%
2020NZ-$22.48-11.57%
2019NZ-$25.4215.24%
2018NZ-$22.06-2.78%
2017NZ-$22.696.93%
2016NZ-$21.22134.88%
2015NZ-$9.03-29.51%
2014NZ-$12.82-57.34%
2013NZ-$30.04146.55%
2012NZ-$12.1820.83%
2011NZ-$10.08-29.41%
2010NZ-$14.29-48.48%
2009NZ-$27.7310%
2008NZ-$25.2111.11%
2007NZ-$22.69-41.3%
2006NZ-$38.66-66.91%
2005NZ-$116.81110.61%
2004NZ-$55.46-61.63%
2003NZ-$144.54186.67%
2002NZ-$50.42
2001N/A-100%
2000NZ-$40.34-63.64%
1999NZ-$110.92

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.29-403.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.29-343.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.29-145.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$11.99-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.23-223.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.80-234.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
NZ$0.61-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA